EGFR and non-small cell lung carcinoma: Considering that wild‐type EGFR downstream pathways could upregulate ERCC1 expression, we question whether the aberrant signals raised by mutant EGFR contribute to downregulation of ERCC1 in mutant EGFR NSCLC cells.